Clinical Trials Logo

Partially Edentulous Mandible clinical trials

View clinical trials related to Partially Edentulous Mandible.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05079048 Completed - Clinical trials for Partially Edentulous Mandible

PEEK Retentive Elements Versus Conventional

PEEK
Start date: July 1, 2017
Phase: N/A
Study type: Interventional

comparing retention and patient satisfaction of implant-supported mandibular overdentures retained by conventional nylon clip and metal housings for ball attachments versus PEEK clip and housings

NCT ID: NCT05016401 Completed - Tooth Loss Clinical Trials

Performance and Safety of Use of the "KONTACT PERIO LEVEL" Transgingival Titanium Dental Implant

KPL
Start date: November 6, 2020
Phase:
Study type: Observational

As part of post-marketing clinical follow-up, BIOTECH DENTAL sets up the collection and evaluation of clinical data proactively with the aim of confirming the safety, performance as well as the constantly acceptable nature of the risks identified and of detecting potential emerging risks with the use of "Kontact Perio Level" implants in everyday practice.

NCT ID: NCT03814655 Completed - Clinical trials for Partially Edentulous Mandible

Evaluation of the Accuracy of Full Digital Workflow for Guided Implant Surgery Using the R2 Gate Software

DIGIMPLGD
Start date: July 1, 2019
Phase: N/A
Study type: Interventional

The primary aim of the present study is to compare the accuracy of a full digital workflow for dental implants insertion to a partially digital workflow, for a limited edentulous space (1 to 3 dental units), in the maxilla or mandible.

NCT ID: NCT01142297 Completed - Type 2 Diabetes Clinical Trials

Comparative Study of Implant Surfaces to Enhance Stabilization in Patients With Type 2 Diabetes

Start date: July 2008
Phase: N/A
Study type: Interventional

This study compares the patterns of dental implant stabilization between a standard and chemically modified implant surface in patients with type 2 diabetes. It is hypothesized that the chemically modified surface will enhance early healing events (first 4 months following placement)in diabetes patients with compromises in rate of implant integration.